BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

663 related articles for article (PubMed ID: 15922768)

  • 1. Snake venoms and coagulopathy.
    White J
    Toxicon; 2005 Jun; 45(8):951-67. PubMed ID: 15922768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procoagulant snake toxins: laboratory studies, diagnosis, and understanding snakebite coagulopathy.
    Isbister GK
    Semin Thromb Hemost; 2009 Feb; 35(1):93-103. PubMed ID: 19308897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematologic effects and complications of snake envenoming.
    Berling I; Isbister GK
    Transfus Med Rev; 2015 Apr; 29(2):82-9. PubMed ID: 25556574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrent coagulopathy after antivenom treatment of crotalid snakebite.
    Bogdan GM; Dart RC; Falbo SC; McNally J; Spaite D
    South Med J; 2000 Jun; 93(6):562-6. PubMed ID: 10881769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current treatment for venom-induced consumption coagulopathy resulting from snakebite.
    Maduwage K; Isbister GK
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3220. PubMed ID: 25340841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major coagulopathy and "nonpoisonous" snake bites.
    Mandell F; Bates J; Mittleman MB; Loy JW
    Pediatrics; 1980 Feb; 65(2):314-7. PubMed ID: 7354978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Could this be snakebite?
    Hawdon GM; Winkel KD
    Aust Fam Physician; 1997 Dec; 26(12):1386-91, 1393-4. PubMed ID: 9470292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral blindness following snakebite.
    Mustapha SK; Mubi BM; Askira BH
    Trop Doct; 2010 Apr; 40(2):117-8. PubMed ID: 20305112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of snakebite poisoning.
    Smith TA; Figge HL
    Am J Hosp Pharm; 1991 Oct; 48(10):2190-6. PubMed ID: 1781479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antivenom efficacy or effectiveness: the Australian experience.
    Isbister GK
    Toxicology; 2010 Feb; 268(3):148-54. PubMed ID: 19782716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous thrombin potential as a novel method for the characterization of procoagulant snake venoms and the efficacy of antivenom.
    Isbister GK; Woods D; Alley S; O'Leary MA; Seldon M; Lincz LF
    Toxicon; 2010 Aug; 56(1):75-85. PubMed ID: 20338189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bedside Coagulation Tests in Diagnosing Venom-Induced Consumption Coagulopathy in Snakebite.
    Wedasingha S; Isbister G; Silva A
    Toxins (Basel); 2020 Sep; 12(9):. PubMed ID: 32927702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A survey on the venomous snakes of the vicinity of Kindia (Guinea) and considerations on the treatment of snakebite].
    Baldé MC; Mané Y; Trape JF
    Med Trop (Mars); 2009 Feb; 69(1):37-40. PubMed ID: 19499730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Envenomation coagulopathy in wounds from pit vipers.
    Simon TL; Grace TG
    N Engl J Med; 1981 Aug; 305(8):443-7. PubMed ID: 7254282
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulopathy after snake envenomation in South Korea.
    Moon JM; Chun BJ; Cho YS; Kim JC; Koo YJ; Park KH; Lee SD; Ahn JS; Kim DK; Ryu SJ
    Clin Toxicol (Phila); 2021 Oct; 59(10):905-912. PubMed ID: 33641566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snakebite.
    Dutta TK; Mukta V
    J Indian Med Assoc; 2006 May; 104(5):250, 252-4. PubMed ID: 17058570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross neutralization of dangerous snake venoms from Africa and the Middle East using the VACSERA polyvalent antivenom. Egyptian Organization for Biological Products & Vaccines.
    Seddik SS; Wanas S; Helmy MH; Hashem M
    J Nat Toxins; 2002 Dec; 11(4):329-35. PubMed ID: 12503876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the Utility of Recombinant Snake Venom Serine Protease Toxins as Immunogens for Generating Experimental Snakebite Antivenoms.
    Alomran N; Blundell P; Alsolaiss J; Crittenden E; Ainsworth S; Dawson CA; Edge RJ; Hall SR; Harrison RA; Wilkinson MC; Menzies SK; Casewell NR
    Toxins (Basel); 2022 Jun; 14(7):. PubMed ID: 35878181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Understanding snake venoms: 50 years of research in Latin America].
    Gutiérrez JM
    Rev Biol Trop; 2002 Jun; 50(2):377-94. PubMed ID: 12298273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.